When corticosteroids are used for these purposes, the systemic agents with the least mineralocorticoid activity (sodium and water retention) should be used. Table 2 provides the anti-inflammatory ...

At the time the licensing agreement was signed in October 2023, ocedurenone – an oral non-steroidal mineralocorticoid receptor antagonist (nsMRA) – was being tested in a phase 3 trial in ...

The primary naturally occurring mineralocorticoid is aldosterone – it’s primary function is the retention of salt. This is important because at higher levels, cortisol may also bind to ...

According to Faubion and Shufelt, 10 the new generations of women will reach menopause with not only more freedom and safety to openly talk about the burden imposed by menopausal signs and symptoms, ...